ANVRX
Price
$10.95
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
551.01M
TRTIX
Price
$26.28
Change
+$0.15 (+0.57%)
Updated
Jun 2 closing price
Net Assets
17.12B
Interact to see
Advertisement

ANVRX vs TRTIX

Header iconANVRX vs TRTIX Comparison
Open Charts ANVRX vs TRTIXBanner chart's image
ANVRX vs TRTIX Comparison Chart in %
View a ticker or compare two or three
VS
ANVRX vs. TRTIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVRX is a Hold and TRTIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRTIX has more cash in the bank: 17.1B vs. ANVRX (551M). ANVRX pays higher dividends than TRTIX: ANVRX (3.06) vs TRTIX (2.52). ANVRX was incepted earlier than TRTIX: ANVRX (7 years) vs TRTIX (11 years). ANVRX (1.68) is less costly to investors than TRTIX (0.68). ANVRX is a more actively managed with annual turnover of: 71.00 vs. TRTIX (15.00). ANVRX has a lower initial minimum investment than TRTIX: ANVRX (2500) vs TRTIX (500000). TRTIX annual gain was more profitable for investors over the last year : 29.56 vs. ANVRX (16.33). TRTIX return over 5 years is better than : 84.98 vs. ANVRX (14.75).
ANVRXTRTIXANVRX / TRTIX
Total Expense Ratio1.680.68247%
Annual Report Gross Expense Ratio1.680.68247%
Fund Existence7 years11 years-
Gain YTD7.14311.05065%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets551M17.1B3%
Annual Yield % from dividends3.062.52121%
Returns for 1 year16.3329.5655%
Returns for 3 years22.0989.1325%
Returns for 5 years14.7584.9817%
Returns for 10 yearsN/A151.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMP86.090.94
+1.10%
Tompkins Financial Corp
ITUB7.860.07
+0.94%
Itau Unibanco Banco Holding SA
QS9.200.06
+0.66%
QuantumScape Corp
ASPC11.05-0.01
-0.05%
A Spac III Acquisition Corp
CNTX2.42-0.37
-13.26%
Context Therapeutics